Profile of nucleotide catabolism and ectonucleotidase expression from the hippocampi of neonatal rats after caffeine exposure

Neurochemical Research

Volumn 37, Issue 1, 2012, Pages 23-30

  Da Silva, R S ^a   Richetti, S K ^a   Tonial, E M ^a   Bogo, M R ^a   Bonan, C D ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Caffeine; Ectonucleotidases; Maternal caffeine intake; Neural development; Nucleotides; Purinergic system

Indexed keywords

5' NUCLEOTIDASE; ACID ANHYDRIDE HYDROLASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CAFFEINE; ECTONUCLEOTIDASE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; NUCLEOTIDASE; NUCLEOTIDE; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATABOLISM; COLORIMETRY; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HIPPOCAMPUS; HYDROLYSIS; LACTATION; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CAFFEINE; DNA PRIMERS; FEMALE; HIPPOCAMPUS; NUCLEOTIDASES; NUCLEOTIDES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 84856267170     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0577-0     Document Type: Article

References (52)

1. Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190(1):S8-S21 (Pubitemid 39451785)
2. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83-133 (Pubitemid 29113867)
3. Herrick-Davis K, Chippari S, Luttinger D, Ward SJ (1989) Evaluation of adenosine agonists as potential analgesics. Eur J Pharmacol 162(2):365-369 (Pubitemid 19083637)
4. Costa MS, Botton PH, Mioranzza S, Souza DO, Porciúncula LO (2008) Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice. Neuroscience 153(4):1071-1078
5. Takahashi RN, Pamplona FA, Prediger RD (2008) Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 13:2614-2632 (Pubitemid 351599708)
6. Black AM, Pandya S, Clark D, Armstrong EA, Yager JY (2008) Effect of caffeine and morphine on the developing pre-mature brain. Brain Res 1219:136-142
7. Zimmerberg B, Carr KL, Scott A, Lee HH, Weider JM (1991) The effects of postnatal caffeine exposure on growth, activity and learning in rats. Pharmacol Biochem Behav 39(4):883-888
8. Da Silva RS, Hoffman A, Souza DO, Lara DR, Bonan CD (2005) Maternal caffeine intake impairs MK-801-induced hyperlocomotion in young rats. Eur J Pharmacol 509(2-3):155-159 (Pubitemid 40279072)
9. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2007) Long-term effects of caffeine therapy for apnea of prematurity. New Eng J Med 357(19):1893-1902 (Pubitemid 350074685)
10. Aliyu MH, Wilson RE, Zoorob R, Brown K, Alio AP, Clayton H, Salihu HM (2009) Prenatal alcohol consumption and fetal growth restriction: potentiation effect by concomitant smoking. Nicotine Tobacco Res 11(1):36-43
11. Millar D, Schmidt B (2004) Controversies surrounding xanthine therapy. Semin Neonatol 9:239-244 (Pubitemid 38525028)
12. Adén U, Herlenius E, Tang LQ, Fredholm BB (2000) Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatric Res 48(2):177-183 (Pubitemid 30497334)
13. Léon D, Albasanz JL, Ruíz MA, Fernandéz M, Martín M (2002) Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J Neurochem 82:625-634 (Pubitemid 34831500)
14. Johansson B, Ahlberg S, van der Ploeg I, Brené S, Lindefors N, Persson H, Fredholm BB (1993) Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 347:407-414 (Pubitemid 23128612)
15. León D, Albasanz JL, Ruíz MA, Martín M (2005) Chronic caffeine or theophylline intake during pregnancy inhibits A1 receptor function in the rat brain. Neuroscience 131:481-489 (Pubitemid 40222455)
16. Rivkees SA, Zhao Z, Porter G, Turner CP (2001) Influences of adenosine on the fetus and newborn. Mol Genet Metab 74:160-171 (Pubitemid 32955157)
17. Turner CP, Yan H, Schwartz M, Othman T, Rivkees SA (2002) A1 adenosine receptor activation induces ventriculomegaly and white matter loss. Neuroreport 13:1199-1204 (Pubitemid 34722053)
18. Zimmermann H (2001) Ecto-nucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52:44-56 (Pubitemid 32401923)
19. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32(1):19-29
20. Zimmermann H (2006) Ectonucleotidases in the nervous system. Novartis Found Symp 276:113-128
21. Braun N, Sévigny J, Mishra SK, Robson SC, Barth SW, Gerstberger R, Hammer K, Zimmermann H (2003) Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur J Neurosci 17(7):1355-1364 (Pubitemid 36560835)
22. Langer D, Ikehara Y, Takebayashi H, Hawkes R, Zimmermann H (2007) The ectonucleotidases alkaline phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones. Neuroscience 150(4):863-879 (Pubitemid 350235788)
23. Stanojevic I, Bjelobabab I, Nedeljkovicc N, Drakulica D, Petrovica S, Stojiljkovicb M, Horvat A (2011) Ontogenetic profile of ecto-5′- nucleotidase in rat brain synaptic plasma membranes. Int J Dev Neurosci 29:397-403
24. Bruno AN, Bonan CD, Wofchuk ST, Sarkis JJ, Battastini AMO (2002) ATP diphosphohydrolase (NTPDase 1) in rat hippocampal slices and effect of glutamate on the enzyme activity in different phases of development. Life Sci 71(2):215-225 (Pubitemid 34595438)
25. Acquas E, Tanda G, Di Chiara G (2002) Differencial effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naïve and caffeine-preteated rats. Neuropsychopharmacology 27:182-193 (Pubitemid 34686970)
26. Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22(15):6321-6324 (Pubitemid 35386385)
27. Da Silva RS, Bruno AN, Battastini AMO, Sarkis JJF, Lara DR, Bonan CD (2003) Acute caffeine treatment increases extracellular nucleotide hydrolysis from rat striatal and hippocampal synaptosomes. Neurochem Res 28(8):1273-1278 (Pubitemid 36734558)
28. Chan K, Delfert D, Junguer KD (1986) A direct colorimetric assay for Ca 2-ATPase activity. Anal Biochem 157:375-380 (Pubitemid 16027071)
29. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:218-254
30. Oses JP, Viola GG, de Paula Cognato G, Júnior VH, Hansel G, Böhmer AE, Leke R, Bruno AN, Bonan CD, Bogo MR, Portela LV, Souza DO, Sarkis JJ (2007) Pentylenetetrazol kindling alters adenine and guanine nucleotide catabolism in rat hippocampal slices and cerebrospinal fluid. Epilep Res 75(2-3):104-111 (Pubitemid 47049817)
31. Bona E, Adén U, Fredholm BB, Hagberg H (1995) The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatr Res 38(3):312-318
32. Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 55(9):1350-1358
33. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. J Am Med Assoc 283(20):2674-2679 (Pubitemid 30337329)
34. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidem 156(5):445-453 (Pubitemid 34976983)
35. Dall'Igna OP, Porciúncula LO, Souza DO, Cunha RA, Lara DR (2003) Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol 138(7):1207-1209 (Pubitemid 36543116)
36. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142(4):941-952 (Pubitemid 44740473)
37. Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutri 46(2):101-123
38. Ritchie K, Carrière I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: a prospective population study (the three city study). Neurology 69(6):536-545 (Pubitemid 47357260)
39. Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova A, Pezzola A, Regio R, Muller CE, Fuxe K, Goldberg SR, Popoli P, Ferre S (2003) Involvement of adenosine A1 and A2a receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsichopharmacology 28(7):1281-1291 (Pubitemid 41070898)
40. Noschang CG, Krolow R, Pettenuzzo LF, Avila MC, Fachin A, Arcego D, von Pozzer Toigo E, Crema LM, Diehl LA, Vendite D, Dalmaz C (2009) Interactions between chronic stress and chronic consumption of caffeine on the enzymatic antioxidant system. Neurochem Res 34(9):1568-1574
41. Da Silva RS, Richetti SK, Da Silveira VG, Battastini AM, Bogo MR, Lara DR, Bonan CD (2008) Maternal caffeine intake affects acetylcholinesterase in hippocampus of neonate rats. Int J Dev Neurosci 26(3-4):339-343
42. Gasior M, Jaszyna M, Peters J, Goldberg SR (2000) Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose. J Pharmacol Exp Therap 295(3):1101-1111
43. Zhang LI, Poo MM (2001) Electrical activity and development of neural circuits. Nat Neurosci 4:1207-1214 (Pubitemid 33733110)
44. Neary JT (1996) Trophic actions of extracellular ATP on astrocytes, synergistic interactions with fibroblast growth factors and underlying signal transduction mechanisms. Ciba Found Symp 198:130-139 (Pubitemid 126793184)
45. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purine in neurons and glial cells. Prog Neurobiol 59(6):663-690 (Pubitemid 29457587)
46. Nedeljkovic N, Banjac A, Horvat A, Stojiljkovic M, Nikezic G (2005) Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex. Int J Dev Neurosci 23:45-51 (Pubitemid 40261236)
47. Li W, Dai S, An J, Li P, Chen X, Xiong R, Liu P, Wang H, Zhao Y, Zhu M, Liu X, Zhu P, Chen JF, Zhou Y (2008) Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model. Neuroscience 151(4):1198-1207
48. Queiroz G, Meyer DK, Meyer A, Starke K, von Kugelgen I (1999) A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91:1171-1181 (Pubitemid 29225645)
49. Sneddon P, Burnstock G (1984) ATP as a co-transmitter in rat tail artery. Eur J Pharmacol 106(1):149-152 (Pubitemid 15189037)
50. Weaver DR (1996) A1-adenosine receptor gene expression in fetal rat brain. Dev Brain Res 94:205-223 (Pubitemid 26292265)
51. Desfrere L, Olivier P, Schwendimann L, Catherine V, Gressens P (2007) Transient inhibition of astrocytogenesis in developing mouse brain following postanatal caffeine exposure. Pediatric Res 62(5):604-609 (Pubitemid 351338998)
52. Heyliger CE, Panagia V, Dhalla NS (1981) Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5′-nucleotidase. J Pharmacol Exp Therap 217(2):489-493 (Pubitemid 11112743)